Gene Expression Assay for Inflammation Source Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods are inadequate for rapidly identifying the source of inflammation, as they fail to differentiate between various causes such as bacterial infections, autoimmune diseases, and aseptic conditions, leading to challenges in appropriate treatment and drug screening.
Innovation Solution
A method based on analyzing white cells from affected areas, utilizing differential gene expression patterns to identify specific protein markers, allowing for differentiation between inflammation sources through comparison with known conditions, using techniques like PCR, RT-PCR, and microarrays to assess gene expression in synovial fluid biopsies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current diagnostic methods are used to identify inflammation sources, then the diagnostic process is simple and quick, but the ability to differentiate between various causes (bacterial infections, autoimmune diseases, aseptic conditions) is insufficient
Solution Approach 1:
The diagnostic method segments the analysis by examining specific gene expression patterns in white blood cells rather than using general inflammation markers. This segmentation allows differentiation between bacterial infections, autoimmune diseases, and aseptic conditions by identifying unique gene expression signatures for each etiology, thereby improving diagnostic precision without requiring overly complex procedures
Solution Approach 2:
The patent uses gene expression patterns as an intermediary marker to indirectly identify the source of inflammation. Instead of directly detecting pathogens or autoimmune markers, the method analyzes the transcriptional response of white blood cells, which serves as a mediator that reflects the underlying cause of inflammation while simplifying the diagnostic approach
2Measurement precision
If gene expression analysis is used to differentiate inflammation sources, then diagnostic accuracy is improved, but the time required for diagnosis increases
Solution Approach 1:
The patent employs real-time quantitative PCR technology that allows for preliminary amplification and detection of specific gene expression patterns during the sample processing itself. This preliminary action enables the diagnostic system to identify inflammation sources without requiring multiple sequential steps, thereby reducing overall diagnosis time while maintaining high accuracy
Solution Approach 2:
The method changes the measurement parameter from general inflammation markers to specific gene expression levels that can be quantified rapidly using PCR. By focusing on a limited set of key genes with distinct expression patterns for different inflammation etiologies, the system achieves rapid differentiation without time-consuming comprehensive analysis
3Measurement precision
If comprehensive gene expression profiling is performed, then the ability to identify specific inflammation causes is enhanced, but the cost and complexity of the diagnostic procedure increase
Solution Approach 1:
The patent extracts and focuses on specific gene expression patterns that are most discriminatory for differentiating inflammation etiologies. Rather than analyzing the entire genome or transcriptome, the method selects and measures only the key genes that provide the most information for diagnosis, thereby reducing procedural complexity while maintaining high etiology identification capability
Solution Approach 2:
The diagnostic method uses a universal PCR-based platform that can detect multiple gene expression patterns simultaneously. This multi-functional approach allows the same diagnostic system to identify bacterial infections, autoimmune diseases, and aseptic conditions using a single procedure, reducing overall complexity compared to having separate tests for each etiology
Data Source
AI summary
A method of diagnosing the source of local, acute inflammation has been developed based on the discovery that white cells have different patterns of gene expression, and therefore protein markers, depending on the origin of the inflammation. These differences can be readily accessed by analysis of the white cells obtained at a site to be analyzed, for example, in the synovial fluid of a knee. The analysis, by comparison with the analysis of white cells present in known conditions, can be used to differentiate between inflammation due to bacterial infection, arthritis or gout, for example. The examples demonstrate differential gene expression in cells present in synovial fluid biopsies from patients with confirmed bacterial infection as compared to patients with aseptic loosening or patients with inflammation due to gout.